Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Abiomed Inc (NASDAQ:ABMD)

Friday’s trading has closed, but ABMD is being traded in the after-hours session. After-Hours quote »
93.82
Delayed Data
As of 3:59pm ET
 -0.34 / -0.36%
Today’s Change
21.84
Today|||52-Week Range
110.68
+146.51%
Year-to-Date

Today’s Trading

Previous close94.16
Today’s open92.87
Day’s range92.55 - 94.57
Volume438,503
Average volume (3 months)748,461
Market cap$4.0B
Dividend yield--
Data as of 3:59pm ET, 09/04/2015

Growth & Valuation

Earnings growth (last year)+1,372.22%
Earnings growth (this year)-73.54%
Earnings growth (next 5 years)+17.00%
Revenue growth (last year)+25.41%
P/E ratio33.2
Price/Sales13.32
Price/Book13.35

Competitors

 Today’s
change
Today’s
% change
WSTWest Pharmaceutical ...-0.30-0.54%
MRMindray Medical Inte...-0.25-1.04%
NUVANuVasive Inc-0.48-0.93%
IARTIntegra LifeSciences...-0.44-0.71%
Data as of 4:02pm ET, 09/04/2015

Financials

Next reporting dateNovember 5, 2015
EPS forecast (this quarter)$0.14
Annual revenue (last year)$230.3M
Annual profit (last year)$113.7M
Net profit margin49.36%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Michael R. Minogue
Chief Operating Officer
David M. Weber
Corporate headquarters
Danvers, Massachusetts

Forecasts

Partner Offers